Novel intracellular oncogenic functions of CTLA4 in melanoma

Ended Project Grant Awarded Last action

Award ID
W81XWH2210442
Recipient
Awarding agency
Obligated
$1,188,750

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Philadelphia, PA 19122, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Temple University-Of The Commonwealth System Of Higher Education will research novel intracellular oncogenic functions of CTLA4 in melanoma under a $1.19 million Project Grant from the Department of the Army Medical Command. The grant was awarded on August 1, 2022 for a three-year period concluding on July 31, 2025.

The research is being conducted under the Military Medical Research and Development program administered by the Department of the Army Medical Command. This program aims to transform military and public health through innovative biomedical research, including investigating medical solutions for battlefield wounds. Temple University will explore new functions of CTLA4, a protein that plays a role in the immune system's response to cancer, to advance understanding and treatment of melanoma.

Quick answers

Who received award W81XWH2210442?

W81XWH2210442 was awarded to Temple University-Of The Commonwealth System Of Higher Education by Medical Command (Department of the Army) on August 1, 2022.

How much is award W81XWH2210442 worth?

$1,188,750 has been obligated on W81XWH2210442.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login